Comparison of naveibine and cisplatin versus gemcitabine and cisplatin in refractory metastatic breast cancer
- VernacularTitle:NC与GC方案治疗耐药晚期乳腺癌近期疗效对照研究
- Author:
Zhong-Fu SHAO
;
Gang XU
;
Ming ZHOU
;
Yong-Dong CHEN
;
- Publication Type:Journal Article
- Keywords:
Breast neoplasms;
Antineoplastic combined chemotherapy protocols
- From:
Cancer Research and Clinic
1999;0(05):-
- CountryChina
- Language:Chinese
-
Abstract:
0.05).The degreeⅢ～Ⅳthrombocytopenia was more common in group A than in group B,but the degreeⅢ～Ⅳhypolekocytosis and phlebitis was more serious in group B.Conclusion NC and GC for treating refractory metastatic breast cancer have a high response rate and tolerable side effects.
